GT201300307A - "derivados de pirazol útiles como inhibidores de aldosterona sintasa" - Google Patents

"derivados de pirazol útiles como inhibidores de aldosterona sintasa"

Info

Publication number
GT201300307A
GT201300307A GT201300307A GT201300307A GT201300307A GT 201300307 A GT201300307 A GT 201300307A GT 201300307 A GT201300307 A GT 201300307A GT 201300307 A GT201300307 A GT 201300307A GT 201300307 A GT201300307 A GT 201300307A
Authority
GT
Guatemala
Prior art keywords
sintasa
inhibitors
aldosterona
useful
pirazol
Prior art date
Application number
GT201300307A
Other languages
English (en)
Inventor
Michael Gregory Bell
Ana Maria Escribano
Paul J Hoogestraat
Thomas Edward Mabry
Quanrong Shen
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46317515&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT201300307(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of GT201300307A publication Critical patent/GT201300307A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A INHIBIDORES DE ALDOSTERONA SINTASA DERIVADOS DE PIRAZOL, INTERMEDIARIOS, MÉTODOS PARA SU PREPARACIÓN, PREPARACIONES FARMACÉUTICAS Y MÉTODOS PARA SU USO.
GT201300307A 2011-06-14 2013-12-11 "derivados de pirazol útiles como inhibidores de aldosterona sintasa" GT201300307A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161496657P 2011-06-14 2011-06-14
US201161506349P 2011-07-11 2011-07-11

Publications (1)

Publication Number Publication Date
GT201300307A true GT201300307A (es) 2014-11-24

Family

ID=46317515

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201300307A GT201300307A (es) 2011-06-14 2013-12-11 "derivados de pirazol útiles como inhibidores de aldosterona sintasa"

Country Status (33)

Country Link
US (1) US8778984B2 (es)
EP (1) EP2721009B1 (es)
JP (1) JP5890012B2 (es)
KR (1) KR101555119B1 (es)
CN (1) CN103596930B (es)
AR (1) AR086665A1 (es)
AU (1) AU2012271023A1 (es)
BR (1) BR112013031873A2 (es)
CA (1) CA2836804C (es)
CL (1) CL2013003536A1 (es)
CO (1) CO6821955A2 (es)
CR (1) CR20130601A (es)
CY (1) CY1116687T1 (es)
DK (1) DK2721009T3 (es)
DO (1) DOP2013000284A (es)
EA (1) EA201391655A1 (es)
EC (1) ECSP13013080A (es)
ES (1) ES2548210T3 (es)
GT (1) GT201300307A (es)
HK (1) HK1193103A1 (es)
HR (1) HRP20150939T1 (es)
HU (1) HUE026461T2 (es)
IL (1) IL229485A0 (es)
ME (1) ME02223B (es)
MX (1) MX336042B (es)
PE (1) PE20140606A1 (es)
PL (1) PL2721009T3 (es)
PT (1) PT2721009E (es)
RS (1) RS54269B1 (es)
SG (1) SG194822A1 (es)
SI (1) SI2721009T1 (es)
TW (1) TWI518073B (es)
WO (1) WO2012173849A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6596417B2 (ja) * 2014-07-04 2019-10-23 日本たばこ産業株式会社 インドール化合物の製造方法
CN108586221B (zh) * 2018-06-26 2021-03-02 常州制药厂有限公司 用于制备替卡格雷的中间体及其制备方法
CN112409432B (zh) * 2020-11-16 2023-07-07 陕西理工大学 一种依西美坦的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57165369A (en) * 1981-04-06 1982-10-12 Teijin Ltd Pyrazole derivative and its preparation
US4617307A (en) * 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5057521A (en) 1988-10-26 1991-10-15 Ciba-Geigy Corporation Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
WO2007111175A1 (ja) 2006-03-17 2007-10-04 Ngk Insulators, Ltd. 目封止ハニカム構造体の製造方法
EP2507234B1 (en) 2009-11-30 2014-03-12 Novartis AG Imidazole derivatives as aldosterone synthase inhibitors
KR101412206B1 (ko) 2010-01-14 2014-06-25 노파르티스 아게 부신 호르몬 조절제의 용도

Also Published As

Publication number Publication date
CN103596930B (zh) 2015-05-13
JP5890012B2 (ja) 2016-03-22
CO6821955A2 (es) 2013-12-31
PE20140606A1 (es) 2014-05-17
TW201311647A (zh) 2013-03-16
DK2721009T3 (en) 2015-10-26
WO2012173849A1 (en) 2012-12-20
KR20140009564A (ko) 2014-01-22
ECSP13013080A (es) 2014-01-31
HRP20150939T1 (en) 2015-10-09
AU2012271023A1 (en) 2013-11-28
NZ617642A (en) 2015-11-27
TWI518073B (zh) 2016-01-21
US20120322841A1 (en) 2012-12-20
CA2836804A1 (en) 2012-12-20
JP2014517034A (ja) 2014-07-17
PL2721009T3 (pl) 2016-01-29
CN103596930A (zh) 2014-02-19
HK1193103A1 (en) 2014-09-12
CL2013003536A1 (es) 2014-07-11
DOP2013000284A (es) 2014-06-30
PT2721009E (pt) 2015-10-23
KR101555119B1 (ko) 2015-09-22
EP2721009B1 (en) 2015-08-12
SG194822A1 (en) 2013-12-30
RS54269B1 (en) 2016-02-29
CR20130601A (es) 2014-05-02
ES2548210T3 (es) 2015-10-14
ME02223B (me) 2016-02-20
BR112013031873A2 (pt) 2016-12-13
MX2013014790A (es) 2014-01-24
CA2836804C (en) 2016-05-24
MX336042B (es) 2016-01-07
EA201391655A1 (ru) 2014-07-30
CY1116687T1 (el) 2017-03-15
HUE026461T2 (en) 2016-05-30
SI2721009T1 (sl) 2015-10-30
US8778984B2 (en) 2014-07-15
EP2721009A1 (en) 2014-04-23
AR086665A1 (es) 2014-01-15
IL229485A0 (en) 2014-01-30

Similar Documents

Publication Publication Date Title
SV2017005487A (es) Derivados de 4h-pirrol[3,2-c]piridin-4-ona
ECSP12011581A (es) Inhibidores de bace
UY34350A (es) Derivados de pirazolquinolinona, su preparación y su uso terapéutico.
GT201400127A (es) Anticuerpos anti-phf-tau y sus usos
MX2021001231A (es) Compuestos heterociclicos y sus usos.
CR20140106A (es) Compuestos y composiciones como inhibidores de la quinasa c-kit
MX347038B (es) Proteínas de membrana solubles en agua y métodos para la preparación y uso de las mismas.
EA201390203A1 (ru) Способы получения тубулизинов
EA201391719A1 (ru) Хиназолиновые производные для лечения вирусных инфекций и дальнейших заболеваний
EA201270722A1 (ru) Формы рифаксимина и их применение
GT201200321A (es) Derivados de heteroaril imidazolona como inhibidores de jak
BR112015002755A2 (pt) derivado de ácido hialurônico, método de preparação de derivado de ácido hialurônico, método de modificação de derivado de ácido hialurônico e uso de derivados
BR112014026926A2 (pt) uso terapêutico de produtos de semente de chardonnay
CO7020907A2 (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas y métodos de uso de los mismos
GT201400017A (es) Derivados de piridin-2 (1h) -ona como inhibidores de jak
BR112014006482A2 (pt) uso de derivados de isossorbida para produção de preparações cosméticas
CO7091179A2 (es) Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos
CO6970609A2 (es) Composición farmacéutica y métodos de uso de derivados de 4-pregenen-11ß-17-21-triol-3,20-diona
UY34356A (es) Derivados de estra-1,3,5(10),16-tetraen-3-carboxamida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos
UY34314A (es) Derivados de anilina, su preparación y su aplicación terapéutica.
UY35906A (es) Novedosos derivados de bencimidazol como ligandos de ep4
MX2015012416A (es) Compuestos heterociclicos y sus usos.
BR112014009760A2 (pt) análogos de ácido siálico, seu uso e composição farmacêutica e composição farmacêutica de liberação sustentada os compreendendo
DOP2015000007A (es) Métodos para preparar triazolopiridinas sutituidas
GT201300003A (es) Forma cristalina delta de la sal de arginina de perindoprilo, su procedimiento de preparacion , y las composiciones farmacèuticas que la contienen